Sanofi

In News

Sanofi and Pfizer get another conjugate blow | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Oncology Pipeline - Apr 15, 2026

Merck, Sanofi are latest companies to add medications to TrumpRx - Fox Business

Fox Business - Apr 13, 2026

EU backs Dupixent for children with CSU as Sanofi (SNY) advances lunsekimig - Stock Titan

Stock Titan - Apr 15, 2026

Sanofi Expands Respiratory Portfolio With Nuvaxovid Role And Lunsekimig Data - simplywall.st

simplywall.st - Apr 15, 2026

Sanofi’s Lunsekimig Delivers Positive Phase 2 Respiratory Data, Bolstering Asthma Pipeline - TipRanks

TipRanks - Apr 15, 2026

Sanofi’s bispecific scores double respiratory phase 2 wins, but flunks eczema study - Fierce Biotech

Fierce Biotech - Apr 07, 2026

Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off - BioSpace

BioSpace - Apr 07, 2026

With Sanofi and Pfizer deals, Novavax bets on ‘amplification strategy’ to drive vaccines engine - Fierce Pharma

Fierce Pharma - Apr 06, 2026

Sanofi: Information concerning the total number of voting rights and shares - March 2026 - GlobeNewswire

GlobeNewswire - Apr 14, 2026

Sanofi immune drug hopeful posts mixed results in mid-stage tests - BioPharma Dive

BioPharma Dive - Apr 07, 2026

A Million Conversations: Bridging Trust Gap - Sanofi

Sanofi - Feb 12, 2026

ADEL Raises $33M In Pre-IPO Round After Major Sanofi Deal - Citeline News & Insights

Citeline News & Insights - Apr 13, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment